Furutani Motoki, Kimura Tetsuaki, Fukunaga Koya, Suganuma Mutsumi, Takemura Marie, Matsui Yasumoto, Satake Shosuke, Nakano Yukiko, Mushiroda Taisei, Niida Shumpei, Ozaki Kouichi, Hosoyama Tohru, Shigemizu Daichi
Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan,
Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Japan.
Gerontology. 2025;71(5):376-387. doi: 10.1159/000545298. Epub 2025 Mar 18.
Age-related alterations in muscle tissue morphology and function, as well as chronic pro-inflammatory conditions, contribute to the development of sarcopenia. To elucidate the multidimensional pathogenesis of sarcopenia, we performed a comprehensive genetic analysis, including common variants, rare variants, and human leukemia antigen (HLA).
A total of 129 older adults were analyzed using whole-genome sequencing (WGS), including 67 sarcopenia patients and 62 normal controls. Sarcopenia was diagnosed according to the Asian Working Group for Sarcopenia 2019 consensus. WGS data and associated clinical data were obtained from the National Center for Geriatrics and Gerontology Biobank in Japan. We performed logistic regression adjusted for age, sex, and body mass index for common variant (minor allele frequency [MAF] ≧0.01), rare variant (MAF <0.01), and HLA analyses. For the functional analysis, we performed RNA interference using human myoblasts and estimated gene expressions (MYOG, MYMK, MYMG) by quantitative PCR.
Rare variant analysis identified five rare coding variants of genes - SLC41A3, SYNRG, CLUAP1, CCHCR1, and ALDH2 - expressed in skeletal muscle. Of these, a deleterious frameshift deletion in SLC41A3 was associated with the pathogenesis of sarcopenia (p = 0.0012, odds ratio [OR] = 11.52, 95% confidence interval [CI] = 2.62-50.69). This deletion significantly reduced expression of myogenin (MYOG), a factor involved in myoblast differentiation (p = 0.0094), but did not affect the fusion of myogenic cells. We also discovered a new protective allele, HLA-DPB1*02:01 associated with sarcopenia (OR = 0.17, 95% CI = 0.060-0.51, p = 0.0015), which has a high occurrence rate in the Northeast Asian population.
Rare variant analysis identified a deleterious frameshift deletion in SLC41A3 as a risk factor for sarcopenia. Our findings suggest that the suppression of MYOG could play a role in myogenesis or muscle maintenance, although this mutation did not impact the terminal differentiation of human myoblasts. Additionally, HLA analysis revealed that HLA-DPB1*02:01 has a protective effect, especially in Northeast Asian populations. Our study enhances the understanding of the etiology of sarcopenia and provides new insights into the mechanisms of its pathogenesis.
肌肉组织形态和功能的年龄相关性改变以及慢性促炎状态,均有助于肌少症的发生发展。为阐明肌少症的多维度发病机制,我们进行了全面的基因分析,包括常见变异、罕见变异和人类白细胞抗原(HLA)。
使用全基因组测序(WGS)对总共129名老年人进行分析,其中包括67名肌少症患者和62名正常对照。根据2019年亚洲肌少症工作组共识诊断肌少症。WGS数据及相关临床数据来自日本国立老年医学和老年学中心生物样本库。我们针对常见变异(次要等位基因频率[MAF]≧0.01)、罕见变异(MAF<0.01)和HLA分析,进行了年龄、性别和体重指数校正的逻辑回归分析。对于功能分析,我们使用人成肌细胞进行RNA干扰,并通过定量PCR估计基因表达(MYOG、MYMK、MYMG)。
罕见变异分析鉴定出在骨骼肌中表达的5个基因的罕见编码变异——SLC41A3、SYNRG、CLUAP1、CCHCR1和ALDH2。其中,SLC41A3中一个有害的移码缺失与肌少症的发病机制相关(p = 0.0012,比值比[OR]=11.52,95%置信区间[CI]=2.62 - 50.69)。该缺失显著降低了成肌调节因子(MYOG)的表达,MYOG是参与成肌细胞分化的一个因子(p = 0.0094),但不影响肌原性细胞的融合。我们还发现了一个与肌少症相关的新的保护性等位基因HLA - DPB1*02:01(OR = 0.17,95% CI = 0.060 - 0.51,p = 0.0015),其在东北亚人群中发生率较高。
罕见变异分析确定SLC41A3中一个有害的移码缺失为肌少症的危险因素。我们的研究结果表明,尽管该突变不影响人成肌细胞的终末分化,但MYOG的抑制可能在肌生成或肌肉维持中起作用。此外,HLA分析显示HLA - DPB1*02:01具有保护作用,尤其是在东北亚人群中。我们的研究增进了对肌少症病因的理解,并为其发病机制提供了新的见解。